VISTAGEN THERAPEUTICS, INC. Current Assets
VISTAGEN THERAPEUTICS, INC. (VTGN) had Current Assets of $34.31 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $34.31M.
- 2026-03-31: Assets, Current $46.94M.
- 2025-12-31: Assets, Current $63.24M.
- 2025-09-30: Assets, Current $78.93M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $34.31M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $46.94M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $63.24M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $78.93M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $66.72M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $82.08M 10-K · filed 2026-06-15 | |
| 2024-12-31 | $89.94M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $99.95M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $110.84M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $120.67M 10-K · filed 2025-06-17 | |
| 2023-12-31 | $128.11M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $39.08M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $11.58M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $17.51M 10-K · filed 2024-06-11 | $17.51M 10-K · filed 2023-06-28 |
| 2022-12-31 | $26.06M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $36.91M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $54.99M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $71.00M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $86.77M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $96.44M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $99.83M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $104.12M 10-K · filed 2022-06-23 | |
| 2020-12-31 | $105.00M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $15.97M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.18M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.58M 10-K · filed 2021-06-29 | |
| 2019-12-31 | $1.38M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $4.68M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $8.78M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $13.63M 10-K · filed 2020-06-29 | $13.65M 10-K · filed 2019-06-25 |
| 2018-12-31 | $7.14M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $8.48M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $7.85M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $11.02M 10-K · filed 2019-06-25 | |
| 2017-12-31 | $13.97M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $2.33M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.13M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $3.38M 10-K · filed 2018-06-26 | |
| 2016-12-31 | $5.77M 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $6.91M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $8.63M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $855.30K 10-K · filed 2017-06-29 | |
| 2015-12-31 | $1.89M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $1.80M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.59M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $105.70K 10-K · filed 2016-06-24 | |
| 2014-12-31 | $75.50K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $189.90K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $554.60K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $40.50K 10-K · filed 2015-06-29 | |
| 2013-12-31 | $91.30K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $154.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $224.70K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $40.50K 10-Q · filed 2014-11-19 | $671.80K 10-K · filed 2013-07-18 |
| 2012-12-31 | $107.00K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $328.40K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $542.90K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $671.80K 10-Q · filed 2013-11-14 | $238.10K 10-K · filed 2012-07-02 |
| 2011-12-31 | $281.93K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $431.95K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.58M 10-Q · filed 2011-08-22 | |
| 2011-03-31 | $204.80K 10-K · filed 2012-07-02 | $204.81K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |